|
Semprex-dDrug - Semprex-d The trade name of the product as shown on the labeling.
Dosage -
CAPSULE; ORAL
Active Ingredient(s) -
Acrivastine; Pseudoephedrine Hydrochloride
Strength -
8MG;60MG
Applicant -
UCB
New Drug Application (NDA) Number -
019806
Product Number -
001
Therapeutic Equivalence (TE) Code -
Approval Date -
Mar 25, 1994
Reference Listed Drug (RLD) -
Yes
Type -
RX
Applicant Full Name -
Ucb Pharma Inc
Semprex-d
Mucomyst 10% Solution; Inhalation, Oral
Mucomyst 20% Solution; Inhalation, Oral Mucosil-10 10% Solution; Inhalation, Oral Mucosil-20 20% Solution; Inhalation, Oral Mucomyst W/ Isoproterenol 10%;0.05% Solution; Inhalation Acylanid 0.1mg Tablet; Oral Soriatane 10mg Capsule; Oral Soriatane 25mg Capsule; Oral Akrinol 2mg/gm Cream; Topical Semprex-d 8mg;60mg Capsule; Oral NewDrugInformation |